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Abstract
The working group “Analyses in Biological Materials” of the Permanent Senate
Commission for the Investigation of Health Hazards of Chemical Compounds in the
Work Area developed the presented biomonitoring method.
The method enables the determination of ochratoxin A in small volumes of serum.
The samples are purified by liquid-liquid extraction and the analyte is extracted from
the acidified sample with dichloromethane. After the extraction agent has been re-
moved, the residue is dissolved in water. The extracts are injected into the capillary,
then the individual components are separated by capillary electrophoresis and de-
tected by laser-induced fluorescence. Coumarin-3-carboxylic acid is used as an inter-
nal standard.
Calibration standards are prepared in serum and processed in the same way as the
samples to be analysed.
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1 Characteristics of the method
Matrix Serum
Analytical principle Capillary electrophoresis with laser-induced fluores-
cence detection (CE-LIF)
Parameter and corresponding hazardous substance
Hazardous substance CAS No. Parameter CAS No.
Ochratoxin A 303-47‑9 Ochratoxin A 303-47‑9
Reliability data
Ochratoxin A
Standard deviation (rel.) sw  = 20.5%, 11.6%, or 4.90%
Prognostic range u = 88.2%, 49.9%, or 21.1%
Within-day precision:
at a spiked concentration of 0.5 µg, 2.0 µg, or 10.0 µg ochratoxin A per litre
of serum and n = 3 determinations
Standard deviation (rel.) sw  = 27.9%, 17.0%, or 6.90%
Prognostic range u = 120%, 73.2%, or 29.7%
Day-to-day precision:
at a spiked concentration of 0.5 µg, 2.0 µg, or 10.0 µg ochratoxin A per litre
of serum and n = 3 determinations
Recovery rate (rel.) r  = 95%Accuracy:
at a spiked concentration of 5.0 µg ochratoxin A per litre of serum and
n = 4 determinations
Detection limit: 0.2 µg ochratoxin A per litre of serum
Quantitation limit: 0.6 µg ochratoxin A per litre of serum
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2 General information on ochratoxin A
Ochratoxin A is a naturally occurring mycotoxin, which was first isolated and chemically characterised in 1965
(Figure 1).
Fig. 1 Structure of ochratoxin A
Ochratoxin A is produced by different fungal species of the Penicillium and Aspergillus genera (Aspergillus
ochraceus, Aspergillus carbonarius, Penicillium verrucosum), which are common and widespread in nature. Myco-
toxins such as ochratoxin A are produced during plant growth, but in most cases, they are produced later on during
the storage of plant material. Accordingly, ochratoxin A can be found in feed for farm animals as well as in food
intended for human consumption.
As far as human nutrition is concerned, ochratoxin A is mainly found in cereals and cereal products (Rizzo et al.
2002), dried fruits, spices (Scheuer and Gareis 2002), nuts (Overy et al. 2003), coffee (Joosten et al. 2001; Taniwaki
et al. 2003), and wine (Battilani and Pietri 2002; Visconti et al. 1999). However, due to its presence in animal feed,
ochratoxin A levels in pork, poultry, and cheese may also contribute to human exposure (CONTAM 2019).
In the European Union, Commission Regulation (EC) No. 1881/2006 (European Commission 2006), sets maximum
levels for ochratoxin A in plant-based foods between 0.5 µg/kg and 20 µg/kg –with the exception of liquorice extract.
The European Food Safety Authority (EFSA) does not currently set a tolerable daily intake (TDI) for ochratoxin A
due to the carcinogenic and genotoxic effects of the substance (CONTAM 2019).
In humans, ingested ochratoxin A can be detected in blood serum (Malir et al. 2016; Thuvander et al. 2001) and in
urine (Malir et al. 2016). The fact that ochratoxin A can be detected in almost all human blood sera, including those
in Germany, suggests that consumers are consistently exposed to ochratoxin A by both plant- and animal-based
foods (Märtlbauer et al. 2009).
While the non-occupationally exposed general population is exposed to ochratoxin A mainly through diet, at the
workplace inhalation of ochratoxin A-containing dusts is also possible. Studies on workers have shown that in-
creased ochratoxin A exposure can occur in food production (Degen et al. 2007), food processing (Iavicoli et al.
2002), and waste management (Degen et al. 2003) (Table 1).
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Tab. 1 Ochratoxin A in serum following occupational exposure
Ochratoxin A in serum [µg/l]Occupational sector (country) Number of
persons n Mean Median Range
References
Malting/barley – July (Germany)   7 – 0.34 0.13–2.60
Malting/barley – October (Germany)   7 – 0.58 0.49–0.93
Controls/general population (Germany)  74 – 0.21 0.07–0.91
Gareis and
Meussdoerffer 2000
Food processing (coffee, cocoa, spices)
(Italy)
  6 2.29 ± 0.99 – 0.94–3.28
Controls (Italy)  23 0.33 ± 0.25 – 0.03–0.95
Iavicoli et al. 2002
Waste deposition (EU)  76 – 0.36 n. s.a)–1.65
Waste sorting and recycling (EU)  60 – 0.53 n. s.–2.89
Controls (EU)  84 – 0.39 n. s.–2.00
Degen et al. 2003
Grain farming (Norway) 106 0.37 – 0.021–2.84
Controls (Norway) 104 0.42 – 0.036–5.53
Skaug 2003
Cargo handling (grain, green coffee)
(Germany)
  9 0.53 ± 0.30 0.42 0.14–1.04 Degen et al. 2005
Grain silos (barley, wheat, rice, oats)
(Germany)
 61 0.28 ± 0.13 0.26 0.07–0.75 Degen et al. 2007
a) not specified
After oral intake, ochratoxin A is rapidly absorbed and is almost completely bound to albumin or other serum
proteins in the human body. This results in a long elimination half-life of up to 35 days. Ochratoxin A is mainly
metabolised to ochratoxin-alpha and is excreted as glucuronide. In humans, ochratoxin A and its metabolites are
primarily excreted via the kidneys, which are also the main target organs for ochratoxin A toxicity (CONTAM
2019).
The Commission has classified ochratoxin A in Carcinogen Category 2 and Category 3 B for germ cell mutagens
(DFG 2020). The IARC (International Agency for Research on Cancer) has classified ochratoxin A as possibly car-
cinogenic to humans (group 2B) (IARC 1993). For further details on the toxicological evaluation of ochratoxin A,
please refer to the relevant MAK documentation (Greim 2006) and the EFSA publication (CONTAM 2019).
The method presented herein has already been published internationally (Köller et al. 2004).
3 General principles
This method allows the determination of ochratoxin A in small volumes of serum. The samples are purified by
liquid-liquid extraction and the analyte is extracted from the acidified sample with dichloromethane. The extract
is evaporated to dryness and the residue dissolved in water. The extracts are introduced into the capillary, the
individual components are separated by capillary electrophoresis and then detected by laser-induced fluorescence.
Coumarin-3-carboxylic acid is used as an internal standard (ISTD).
Calibration standards are prepared in serum and processed in the same way as the samples to be analysed.
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4 Equipment, chemicals and solutions
4.1 Equipment
• Capillary electrophoresis system (e.g. HP3D, Agilent Technologies Deutschland GmbH,Waldbronn, Germany)
• Helium-cadmium laser, 325 nm (e.g. Melles Griot 56 Series, IDEX Health & Science, New York, USA)
• Laser-induced fluorescence-detection system (LIF detector) (e.g. Picometrics ZetaLIF, ADELIS SAS, Grabels,
France)
• Capillary column of fused silica with an inner diameter of 50 µm (e.g. Molex PolymicroTM, Optronics GmbH,
Kehl, Germany)
• Microcentrifuge (e.g. Galaxy 14D, VWR International GmbH, Darmstadt, Germany)
• Vortex mixer (e.g. Vortex 2, IKA-Werke GmbH & Co. KG, Staufen, Germany)
• pH meter (e.g. Knick Elektronische Messgeräte GmbH & Co. KG, Berlin, Germany)
• Precision balance (e.g. Sartorius AG, Göttingen, Germany)
• Beakers (e.g. Brand GmbH & Co. KG, Wertheim, Germany)
• 10-ml, 100-ml and 500-ml volumetric flasks (e.g. VWR International GmbH, Darmstadt, Germany)
• 10-ml volumetric pipette (e.g. Brand GmbH & Co. KG, Wertheim, Germany)
• Variably adjustable microlitre pipettes with matching pipette tips (e.g. Eppendorf AG, Hamburg, Germany)
• 2-ml screw-cap glass vials incl. caps with PTFE septa (e.g. Agilent Technologies Deutschland GmbH,
Waldbronn, Germany)
• 0.5-ml polypropylene reaction vessels (e.g. Eppendorf AG, Hamburg, Germany)
• 0.2-ml polypropylene vials (e.g. Agilent Technologies Deutschland GmbH, Waldbronn, Germany)
• Syringe filters, 0.45 µm (e.g. MACHEREY-NAGEL GmbH & Co. KG, Düren, Germany)
• 4-ml serum monovettes (e.g. Sarstedt AG & Co. KG, Nümbrecht, Germany)
4.2 Chemicals
Unless otherwise specified, all chemicals must be at least pro analysi grade.
• Acetonitrile (e.g. Merck KGaA, Darmstadt, Germany, No. 100017)
• Coumarin-3-carboxylic acid (e.g. Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany, No. C85603)
• Dichloromethane (e.g. Merck KGaA, Darmstadt, Germany, No. 100668)
• Disodium hydrogen phosphate heptahydrate (e.g. Merck KGaA, Darmstadt, Germany, No. 106575)
• Methanol (e.g. Merck KGaA, Darmstadt, Germany, No. 100837)
• Sodium chloride (e.g. Merck KGaA, Darmstadt, Germany, No. 106404)
• Sodium hydrogen carbonate (e.g. Merck KGaA, Darmstadt, Germany, No. 106329)
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• Sodium hydroxide pellets (e.g. Merck KGaA, Darmstadt, Germany, No. 106469)
• Ochratoxin A from A. ochraceus (e.g. Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany, No. O3007)
• ortho-Phosphoric acid 85% (e.g. Merck KGaA, Darmstadt, Germany, No. 100552)
• ortho-Phosphoric acid 20% (e.g. VWR International GmbH, Darmstadt, Germany, No. KRAF20132.2000)
• Ultra-pure water (e.g. Milli-Q plus VE System (>18 MΩ), Merck KGaA, Darmstadt, Germany)
• Argon 5.0 (e.g. Linde GmbH, Pullach, Germany)
4.3 Solutions
All solutions are passed through a 0.45 µm syringe filter prior to use.
• Solution A
Exactly 1.68 g of sodium hydrogen carbonate are weighed into a 100-ml volumetric flask and dissolved in
ultra-pure water. The flask is then made up to the mark with ultra-pure water.
• Solution B
Exactly 1.2 g of sodium chloride are weighed into a 10-ml volumetric flask and dissolved in about 2 ml of
ultra-pure water. 1.3 ml of 85% ortho-phosphoric acid are then added and the flask is made up to the mark
with ultra-pure water.
• Sodium hydroxide solution (1 mol/l)
50 ml of ultra-pure water are placed in a 250-ml beaker. Exactly 4 g of sodium hydroxide pellets are added and
dissolved by stirring. The solution is transferred to a 100-ml volumetric flask, rinsing the beaker with water.
The flask is then made up to the mark with ultra-pure water.
• Sodium hydroxide solution (0.1 mol/l)
10 ml of the 1 mol/l sodium hydroxide solution are placed in a 100-ml volumetric flask, which is then made up
to the mark with ultra-pure water.
• Phosphate buffer (60 mmol/l, pH 7)
Exactly 4.02 mg of disodium hydrogen phosphate heptahydrate are weighed into a 600-ml beaker and dis-
solved in 400 ml of ultra-pure water. The pH is adjusted to pH 7 by adding drops of 20% phosphoric acid. The
solution is then transferred to a 500-ml volumetric flask, which is made up to the mark with ultra-pure water.
The solutions are stored at room temperature and are stable for at least three months under these conditions.
4.4 Internal standard (ISTD)
• ISTD stock solution (2900 mg/l)
Exactly 29 mg of coumarin-3-carboxylic acid are weighed into a 10-ml volumetric flask and dissolved in ace-
tonitrile. The flask is then made up to the mark with acetonitrile.
The ISTD stock solution is stored at −20 ℃ and is stable for at least two months under these conditions.
• ISTD spiking solution (870 mg/l)
330 µl of the ISTD stock solution are thoroughly mixed with 770 µl of ultra-pure water in a 2-ml glass vial.
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The ISTD spiking solution is freshly prepared every workday and passed through a 0.45 µm syringe filter prior
to use.
Fig. 2 Structure of the internal standard (coumarin-3-carboxylic acid)
4.5 Calibration standards
• Ochratoxin A stock solution (500 mg/l)
5 mg of ochratoxin A are weighed exactly into a 10-ml volumetric flask and dissolved in methanol. The flask
is then made up to the mark with methanol.
The ochratoxin A stock solution is stored at −20 ℃. Under these conditions, it is stable without loss of analyte
for at least three months.
• Ochratoxin A working solution 1 (5 mg/l)
100 µl of the ochratoxin A stock solution are pipetted into a 10-ml volumetric flask. The flask is then made up
to the mark with ultra-pure water and the solution is thoroughly mixed.
• Ochratoxin A working solution 2 (250 µg/l)
500 µl of ochratoxin A working solution 1 are pipetted into a 10-ml volumetric flask. The flask is then made
up to the mark with ultra-pure water and the solution is thoroughly mixed.
The ochratoxin A working solutions can be used for a maximum of one week when stored in the refrigerator at
4 ℃.
Spiking solutions in a concentration range between 0.5 µg/l and 250 µg/l are prepared by diluting the ochratoxin A
working solution 2 with ultra-pure water. These spiking solutions are used to prepare the calibration standards by
pipetting 25 µl of the spiking solution each to 100 µl of serum. The calibration standards prepared in this way are
thoroughly mixed on the vortex mixer. Table 2 shows the pipetting scheme for the preparation of the calibration
standards.






Spiking solution Calibration standard
1   10 990   2.5  0.5
2   20 980   5  1
3   50 950  12.5  2.5
4  100 900  25  5
5  200 800  50 10
6  500 500 125 25
7 1000   0 250 50
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The calibration standards are freshly prepared every workday. Depending on the expected exposure levels, the
concentration range of calibration can be adjusted. Usually, calibration up to 10 µg/l should be sufficient.
5 Specimen collection and sample preparation
5.1 Specimen collection
Blood samples are taken using serum monovettes. The monovettes are turned gently several times after blood
collection and then allowed to stand at room temperature for at least 30 minutes. The blood cells are separated by
centrifugation (10 minutes at 3000 rpm; 4 ℃) and the serum is pipetted off.
5.2 Sample preparation
In a 0.2-ml polypropylene vial, 20 µl of solution A are pipetted to 20 µl of serum. The alkaline sample solution (pH
> 9) is extracted twice with 100 µl dichloromethane each.The organic phase is pipetted off and discarded in each case.
The solution is then acidified by adding 100 µl of solution B and extracted three times with 100 µl dichloromethane
each. The extraction steps are performed using a vortex mixer for five minutes each. After extraction, the solution
is centrifuged for 2.5 minutes at 14 000 × g to ensure better phase separation. After centrifugation, a three-phase
system is formed, in which the upper aqueous phase is separated from the lower organic phase by the protein
fraction appearing as a white ring. Each time, the organic phase is transferred into a vial with a conical insert. The
combined extracts are evaporated to dryness under a stream of argon. The residue is dissolved in 20 µl of the ISTD
spiking solution.
Unless a micro approach is required, larger sample volumes can be used.
6 Operational parameters
Analysis is performed using a capillary electrophoresis system coupled with a laser-induced fluorescence detector
(CE-LIF).
The capillary electrophoresis system consists of a thermostated capillary, the ends of which are placed in a cathode
and anode buffer reservoir. The electrodes connected to a high-voltage power supply are also immersed in these
reservoirs. The detection window, which extends through the laser and photocell beam path, is located near the
anode end. The signal from the detector is transmitted to a PC. Figure 3 shows the schematic setup of a CE-LIF
system.
Fig. 3 Schematic setup of a CE-LIF system
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Helium-cadmium laser: 15 mWLIF detector:
Excitation wavelength: 325 nm
Hydrodynamic: 50 mbar for 30 s
Stacking: −20 kV for 30 s
Injection:
Separation: +23 kV (constant)
All settings of the capillary electrophoresis system and of the detector are instrument-specific and must be adjusted
individually by the user. The parameters given are therefore intended only as cursory guidance.
7 Analytical determination
After installation, the capillary is rinsed consecutively with methanol for 15 minutes, with ultra-pure water for
5 minutes, with 1 molar sodium hydroxide solution for 20 minutes, with 0.1 molar sodium hydroxide solution for
10 minutes, and finally with phosphate buffer for 20 minutes.
Furthermore, the capillary is rinsed for daily use with ultra-pure water for 10 minutes, with 1 molar sodium hydrox-
ide solution for 10 minutes, with 0.1 molar sodium hydroxide solution for 10 minutes, and with phosphate buffer
for 15 minutes. An aliquot of the samples, prepared as described in Section 5.2, is injected into the capillary. In-
jection is performed hydrodynamically for 30 seconds with a pressure of 50 mbar. Afterwards, a voltage of −20 kV
is applied. After 30 seconds, the polarity of the electric current is changed by switching to +23 kV. The temporal
variation is recorded for fluorescence excited at 325 nm. The respective electropherogram recorded by the detec-
tor shows a characteristic chart that depends on the sample composition, the type of injection, the detection, and
further parameters.
Identification of ochratoxin A and of the ISTD is based on the migration times (Table 3). The analytical run time is
about 15 minutes. After each measurement, the capillary is rinsed with 0.1 molar sodium hydroxide solution for
one minute and with phosphate buffer for two minutes.
Tab. 3 Migration times for the determination of ochratoxin A in serum
Analyte Migration time [min]
Ochratoxin A ~8.5
Coumarin-3-carboxylic acid ~9.6
The migration times given in Table 3 are intended only as cursory guidance. Users must ensure proper performance
of the CE system used, which influences the resulting migration behaviour of the substances. Figures 4 and 5 show
electropherograms of two sera spiked with 0.5 µg and 1 µg ochratoxin A per litre, respectively.
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Fig. 4 Electropherogram of a serum sample spiked with 0.5 µg ochratoxin A per litre
Fig. 5 Electropherogram of a serum sample spiked with 1 µg ochratoxin A per litre
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8 Calibration
The calibration standards, prepared as described in Section 4.5, are processed in the same way as the samples to
be analysed (cf. Section 5) and analysed by CE-LIF (cf. Section 7). Calibration graphs are obtained by plotting the
quotients of the peak areas of the analyte and the internal standard against the concentration of the calibration
standards. The calibration curve is linear under the described analytical conditions in the concentration range from
0.5 µg/l to 50 µg/l. As an example, Figure 6 shows a calibration curve for ochratoxin A in serum.
Fig. 6 Calibration curve for the determination of ochratoxin A in serum
Depending on the expected exposure levels, the concentration range of calibration can be adjusted. Usually, cali-
bration up to 10 µg/l should be sufficient.
9 Calculation of the analytical results
The analyte concentrations in the serum samples are calculated using the calibration function pertaining to the
corresponding analytical run (Section 8). The analyte concentration of a sample is determined by dividing the peak
area of the analyte by the peak area of the internal standard. The quotient thus obtained is entered into the equation
of the calibration curve established per Section 8 to give the respective analyte concentration in µg/l. Any reagent
blank value has to be subtracted from the analytical results.
10 Standardisation and quality control
Quality control of the analytical results is carried out as stipulated in the guidelines of the Bundesärztekammer
(German Medical Association) and in a general chapter of the MAK Collection for Occupational Health and Safety
(Bader et al. 2010; Bundesärztekammer 2014). To check precision, three quality-control samples with known analyte
concentrations are analysed within each analytical run. As control material is not commercially available, it must be
prepared in the laboratory. To this end, serum is spiked with the standard solution of the analyte at three different
concentration levels, so that the concentration levels of the control materials are within the relevant concentration
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range (e.g. 0.5 µg/l, 2.0 µg/l, 10 µg/l). Aliquots of these samples are stored at −20 ℃ and are included in each analytical
run as quality-control samples. Care must be taken to ensure even distribution within the sequence. The nominal
value and the tolerance ranges of the quality-control materials are determined in a pre-analytical period (Bader
et al. 2010). A reagent blank is included in each analytical run in addition to the quality-control samples.
11 Evaluation of the method
The reliability of the method was verified by comprehensive validation and comparative measurements in a second,
independent laboratory.
11.1 Precision
Within-day precision was determined using the quality-control samples spiked with 0.5 µg, 2.0 µg, and 10 µg ochra-
toxin A per litre of serum (see Section 10). The material was processed and analysed three times in parallel. The
obtained within-day precision data are presented in Table 4.
Tab. 4 Within-day precision for the determination of ochratoxin A in serum (n = 3)
Analyte Spiked concentration [µg/l] Determined level [µg/l] Standard deviation (rel.) sw [%] Prognostic range u [%]
 0.5 0.45 20.5 88.2
 2.0 2.1 11.6 49.9
Ochratoxin A
10.0 9.8  4.9 21.1
Day-to-day precision was determined by processing and analysing spiked serum samples on three consecutive days,
using quality control samples spiked with 0.5 µg, 2.0 µg and 10 µg ochratoxin A per litre of serum (see Section 10).
The obtained day-to-day precision data are presented in Table 5.
Tab. 5 Day-to-day precision for the determination of ochratoxin A in serum (n = 3)
Analyte Spiked concentration [µg/l] Determined level [µg/l] Standard deviation (rel.) sw [%] Prognostic range u [%]
 0.5  0.45 27.9 120
 2.0  2.16 17.0  73.2
Ochratoxin A
10.0 10.5  6.9  29.7
11.2 Accuracy
Recovery was determined using an ochratoxin A solution with a concentration of 5.0 µg/l. The solution was pro-
cessed and analysed four times, yielding recovery rates in the range from 86% to 103% (see Table 6).
Tab. 6 Mean relative recovery rate for the determination of ochratoxin A in serum (n = 4)
Analyte Spiked concentration [µg/l] Mean relative recovery [%] Range [%]
Ochratoxin A 5.0 95 86–103
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11.3 Limits of detection and quantitation
The detection limit and quantitation limit were determined on the basis of a signal-to-noise ratio of 3 : 1 for the
detection limit and of 9 : 1 for the quantitation limit. The values calculated for the determination of ochratoxin A
in serum are shown in Table 7.
Tab. 7 Limit of detection and limit of quantitation for the determination of ochratoxin A in serum (n = 6)
Analyte Detection limit [µg/l] Quantitation limit [µg/l]
Ochratoxin A 0.2 0.6
11.4 Sources of error
With capillary electrophoresis, migration timesmay vary from one analytical run to another. In order to compensate
for these drifts, which may occur due to the installation of a new capillary column or buffer consumption, the
correction method published by Li et al. (2000) can be applied. Matrix components may also interfere with the
migration times of the analyte or of the ISTD. In such cases, it is advisable to spike the sample with 5 µg ochratoxin A
per litre and to repeat the analysis.
12 Discussion of the method
Thedescribedmethod allows the quantification of ochratoxin A in very small volumes of serum. Sample preparation
by means of liquid-liquid extraction is simple and requires little time and effort. The analytical run time from one
measurement to the next is about 15 minutes, so that three to four samples can be analysed per hour. The method
is, however, not suitable for automation.
With capillary electrophoresis, the separation of the sample components is based on their different migration
behaviour in a capillary, to which high voltage is applied. In the case of the applied capillary zone electrophoresis,
a variant of CE, a homogeneous electric field is created by using a buffer solution. Detection is based on the induced
fluorescence of the analytes passing through the detectionwindow of the capillary. Due to the short light path, laser-
induced fluorescence detection is clearly superior to other optical detection methods in terms of both specificity
and sensitivity.
Despite the small sample volumes, a detection limit of 0.2 µg/l could be obtained by using a special injection tech-
nique (stacking). The precision data can be considered satisfactory. Unless a micro approach is required, larger
sample volumes can be used. This should also facilitate sample preparation and processing, and further improve the
precision of the method.
Due to the quantitation limit to be obtained, this method is only suitable for the detection of elevated ochratoxin A
levels in environmental or occupational settings. The background exposure of the general population, which aver-
ages at 0.21 µg ochratoxin A per litre of serum in Germany (see Table 1) cannot be quantified by this method.
Instruments used HP3D capillary electrophoresis system with a PolymicroTM capillary column of fused
silica (Molex PolymicroTM, Optronics GmbH, Kehl, Germany); laser-induced fluorescence detection with helium-
cadmium laser (Melles Griot 56 Series, 325 nm); and Picometrics ZetaLIF detector (Picometrics ZetaLIF, ADELIS
SAS, Grabels, France).
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